IRIS
PESCE, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.231
Totale 5.231
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.231
Totale 5.231
Salva come PNG Salva come JPEG
Città #
Genova 3.908
Rapallo 641
Genoa 629
Vado Ligure 28
Bordighera 25
Totale 5.231
Salva come PNG Salva come JPEG
Nome #
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 163
NK/DC crosstalk in anti-viral response. 153
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 149
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 148
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 147
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor 141
NK cells and their receptors during viral infections. 137
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 134
Bridging innate NK cell Functions with Adaptive Immunity. 133
Features of Memory-Like and PD-1+ Human NK Cell Subsets 127
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 126
Human Natural Killer Cells exposed to IL-2, IL12, IL-18 or IL-4 differently modulate priming of naïve T cells by monocyte-derived Dendritic Cells. 125
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 125
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 120
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway 117
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 115
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 112
Harnessing NK Cells for Cancer Treatment 112
Human NK cell response to pathogens 110
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 108
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 105
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands 104
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 104
TLR/NCR/KIR: Which One to Use and When? 102
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 98
Human NK cells directly recognize Mycobacterium Bovis and acquire the ability to interact with monocyte-derived DC 94
The NK/DC complot 90
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 87
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines. Regulation by KIR/HLA-class I interaction. 86
Human NK cells directly recognize Mycobacterium bovis and acquire the ability to interact with monocyte-derived DC 82
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis 80
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 79
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 77
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 77
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 76
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts. 75
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 74
NK cells to cure cancer 74
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 73
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts. 70
The innate immune cross talk between NK cells and eosinophils is regulated by the interaction of Natural Cytotoxicity Receptors with eosinophil surface ligands 70
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes 65
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 62
Comprehensive Phenotyping of Human PB NK Cells by Flow Cytometry 59
New Insights into Endometrial Cancer 59
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy 58
The NK/DC complot 56
Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection 56
Female Malignancies and Immunotherapy: What's New? 54
The PD-1 immune checkpoint on human NK cells in normal and pathological condition 52
NK Cell-Based Immunotherapy in Colorectal Cancer 50
Regolazione recettore mediata dell’Homing delle cellule NK umane 49
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 47
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 45
Neutrophilic priming of NK cells enhance the response to ensuing IL-12 stimulation 44
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts 38
Harnessing Immune Response in Acute Myeloid Leukemia 33
The PD-1 immune checkpoint on human NK cells in normal and pathological condition 33
Relevant role for PD-1 immune checkpoint expressed on NK cells derived from ovarian cancer patients 31
A CRISPR approach to manipulating NK cell receptor ligand expression in leukemic cells 28
Relevant role for PD-1 immune checkpoint expressed on NK cells derived from ovarian cancer patients 24
Natural killer cell impairment in ovarian clear cell carcinoma 23
NK/DC crosstalk in anti-viral response 21
Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the art 19
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1 18
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans 18
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers 13
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans 3
NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells 1
Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors 1
Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity 1
Totale 5.440
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.312
article - articoli 14.176
book - libri 0
conference - conferenze 2.639
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 497
Totale 34.624
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.405 0 28 42 96 126 180 225 113 159 235 162 39
2020/2021681 47 35 40 37 24 153 23 45 63 101 51 62
2021/2022720 24 36 60 48 48 53 47 171 58 68 35 72
2022/2023777 86 68 6 74 107 120 2 66 143 8 84 13
2023/2024532 27 70 14 65 36 52 39 72 27 27 40 63
2024/202545 36 9 0 0 0 0 0 0 0 0 0 0
Totale 5.440